Transmyocardial laser revascularization (TMLR) will not denervate the heart, because it does not destroy all of the afferents. This study was designed to determine if stimulation of cardiac sympathetic and vagal afferents from an area of the left ventricle treated with TMLR could evoke reflex effects, and thus whether TMLR would denervate the heart.
The effect of TMLR on reflexes evoked by chemically stimulating cardiac afferents was examined in 9 dogs. Bradykinin and capsaicin were applied topically or injected into the left anterior descending coronary artery before and after TMLR and after bilateral vagotomy and sympathectomy. Aortic (AoP) and left ventricular pressures (LVP) and electrocardiography were monitored. The first derivatives of LVP (dP/dt) were calculated.
Topical bradykinin elicited variable hemodynamic responses. Topical capsaicin evoked pressor responses, increasing mean (± SEM) AoP (105±9 to 115±9 mm Hg; P<.001) and positive dP/dt (+dP/dt) (1032±81 to 1159±10 mm Hg/s; P<.01) before TMLR. Intracoronary capsaicin evoked a depressor response before TMLR. Pressor responses remained intact after TMLR with increases in mean AoP and
+dP/dt (115±6 to 128±5 mm Hg and 1039±98 to1136±100 mm Hg/s, respectively; P<.01). Depressor responses also remained intact after TMLR (91±10 vs 101±11 mm Hg [P<.02], and 865±104 vs 931±104 mm Hg/s [P<.05], respectively). Hemodynamic responses were diminished after bilateral vagotomy and abolished after bilateral sympathectomy.
Since activation of cardiac afferent nerves and reflex responses remained intact after TMLR, but changed after vagotomy or sympathectomy, TMLR does not denervate the heart sufficiently to be the cause of improved angina after TMLR.
TRANSMYOCARDIAL laser revascularization (TMLR) is an alternative treatment for patients with refractory angina who are not candidates for angioplasty or bypass surgery.1 In clinical trials, patients treated with TMLR showed improvements in New York Heart Association angina class at up to a 12-month follow-up.2 Although there is extensive experience using TMLR as sole therapy or in conjunction with bypass surgery,3- 5 the mechanism by which TMLR provides angina relief is not clear. It has been postulated that the TMLR channels provide a passage for blood to flow from the ventricle into the myocardium.6,7 However, significant data suggest that TMLR channels do not remain patent, and this hypothesis is falling out of favor.8- 10 Laser injury accompanied by angiogenesis and increased collateral perfusion has been proposed as an alternative mechanism to explain the improvement in perfusion after TMLR.11,12 However, the question of why patients are relieved of their symptoms immediately after surgery has not been answered. Another possible explanation for angina relief immediately after TMLR is denervation of the myocardium. Although evidence has been presented that afferent cardiac responses are inhibited by laser treatment,13,14 other investigators have reported that TMLR does not denervate the heart.15
The heart is innervated by sympathetic and vagus nerves, and cardiac pain is known to travel via sympathetic afferents,16,17 which have multiple endings.18 Thus, unless TMLR ablates major proximal nerve branches, it is unlikely that TMLR would denervate the heart sufficiently to prevent transmission of sensory information. The purpose of our study was to determine, in a canine model, if stimulation of cardiac sympathetic and vagal afferents from an area of the left ventricle treated with TMLR could evoke reflex effects. This approach allowed us to determine whether TMLR altered cardiac chemoreflexes and whether there was a different effect on vagal and sympathetic responses. We studied the effect of TMLR on cardiac reflexes evoked by chemically stimulating cardiac vagal and sympathetic afferents to investigate the controversial hypothesis that TMLR improves angina by denervating afferent nerve fibers.
Experiments were performed on 9 mongrel dogs (body weight, 20-25 kg). All animals received humane care in compliance with the Principles of Laboratory Animal Care formulated by the National Society for Medical Research. The Institutional Animal Care and Use Committee reviewed and approved this study.
Animals were anesthetized with intravenous thiopental sodium (Pentothal) (15 mg/kg) and intubated, and their lungs were ventilated with an oxygen mixture by a veterinary anesthesia ventilator (Model 2000; Hallwell, Inc, Pittsfield, Mass). Anesthesia was maintained by continuous intravenous infusion of pentobarbital sodium (4mg/kg per hour). Electrocardiography (ECG) (lead II) was monitored. The left carotid artery was isolated, and a catheter transducer (Mikro-tip; Millar Instrument Inc, Houston, Tex) was inserted into the aorta to measure aortic pressure (AoP). The right femoral artery was isolated, and another catheter (Millar Instrument Inc) was inserted into the left ventricle to measure the left ventricular pressure (LVP). Both cervical vagus nerves were isolated. The left chest was entered by a left lateral thoracotomy incision through the fifth intercostal space in 6 animals. In the other 3 animals, a midsternotomy was performed to allow for exposure of the stellate ganglia and sympathetic chains. In 4 animals, a catheter (Angiocath 20; Becton Dickinson, Sandy, Utah) was inserted into the left anterior descending coronary artery (LAD), proximal to the second diagonal artery. The LVP, AoP, and ECG were recorded using a thermal array recorder (TA11; Gould Instrument Systems Inc, Valley View, Ohio) and simultaneously using a computerized data acquisition system (Labtech, Andover, Mass).
We stimulated chemically sensitive cardiac afferents before and after TMLR and after interrupting vagal and sympathetic pathways. Bradykinin and capsaicin (Sigma-Aldrich Corp, St Louis, Mo) were used to stimulate cardiac sensory (vagal and sympathetic) afferents by topical application and by injection into the LAD. For topical application, each test solution (with different concentrations) was selected randomly, and applied to the anterior wall of the left ventricle with a piece of filter paper (2 × 2 cm2), and then removed. We continued the protocol with the chemical that gave the more prominent cardiac response. After each application, the epicardium was rinsed with isotonic sodium chloride solution. Bradykinin was applied to all animals, and capsaicin was applied to 6 animals. In 4 animals, doses of capsaicin or bradykinin were also injected into the LAD to elicit cardiac reflexes. The interval between testings was 15 minutes.
Laser transmyocardial channels (average, 24) were made in the anterior wall of the left ventricle in the LAD distribution at a density of 1/cm2. The animals were then allowed to stabilize for 30 to 60 minutes before applying chemical agents. Topical application and LAD injection of bradykinin or capsaicin were repeated after TMLR. The cervical vagus nerves were then cut, and topical applications or LAD injections of bradykinin or capsaicin were repeated. In midsternal-approach animals, the stellate ganglia and sympathetic chains (T1-T4) were transected bilaterally, and epicardial stimulation with capsaicin or bradykinin was repeated. Animals were killed humanely with pentobarbital and potassium chloride after all protocols were completed.
During each application or injection of bradykinin and capsaicin, LVP, AoP, and ECG data were collected continuously for 2 minutes (pre-TMLR). Using software developed in Visual Basic for Excel (Microsoft Excel 7.0; Microsoft Inc, Redwood, Wash), we extracted hemodynamic variables from the stored data file. Mean AoP, heart rate, and the first derivatives (positive and negative) of LVP (+dP/dt and −dP/dt) were calculated. Data were reported as mean±SE. A paired t test was used to compare baseline data within a group with data after administration of bradykinin or capsaicin. Responses during pre-TMLR (control responses), after TMLR, after vagotomy, or after sympathectomy were compared by a 1-way repeated-measures analysis of variance (RMANOVA) and identified with a Tukey comparison test. Differences were considered significant at P<.05.
The TMLR procedure did not change the hemodynamic responses to topical bradykinin or to topical and intracoronary capsaicin. Topical application of bradykinin elicited depressor responses in 3 dogs, pressor responses in 2, and no changes in the remaining 4. The hemodynamic responses induced by topical application of bradykinin in the animals that had a response are shown in Table 1. Topical application of capsaicin evoked pressor responses in 6 of 6 dogs, increasing mean AoP from 105±9 to 115±9 mm Hg (a 10%±1% increase; P<.001) and +dP/dt from 1032±81 to 1159±10 mm Hg/s (a 12%±2% increase; P<.01). On average, the heart rate did not change significantly from control (83±3 to 84±4 beats/min). After TMLR, the pressor response remained intact. Topical application of capsaicin also increased mean AoP (12%±4%; P<.01) and +dP/dt (11%±3%; P<.02). However, the presssor response to capsaicin was significantly decreased after bilateral vagotomy and completely abolished after bilateral sympathectomy and vagotomy (Figure 1 and Figure 2).
Pressor response evoked by epicardial application of capsaicin (n=6). TMLR indicates transmyocardial laser revascularization; Vx, bilateral cervical vagotomy; Sx, bilateral section of the stellate ganglia and sympathetic chains (T1-T4); dP/dt, positive and negative first derivatives of left ventricular pressure; asterisk,P<.05 compared with baseline; and dagger, P<.05 compared with control (pre-TMLR) response. Bars indicate percentage of changes in mean aortic pressure and dP/dt from control (mean±SEM). The TMLR did not significantly alter the response to epicardial application of capsaicin, but mean aortic pressure and positive dP/dt were decreased by bilateral vagotomy and were abolished by bilateral sympathectomy (n=3).
Pressor response abolished by bilateral sympathectomy. Abbreviations are given in the legend to Figure 1. This tracing represents the response of one animal and shows a typical response to capsaicin after bilateral vagotomy and sympathectomy. The pressor response was completely abolished after bilateral sympathectomy.
In 3 of 4 dogs that had injection of capsaicin into the LAD, mean AoP decreased from 101±11 to 91±10 mm Hg (−10%±2%; P<.02), +dP/dt decreased from 931±104 to 865±104 mm Hg/s (−7%±2%; P<.05), and −dP/dt increased from −846±55 to −735±74 mm Hg/s (13%±3%; P<.02). In these dogs, mean heart rate (84±6 beats/min) did not change significantly after capsaicin injection. The depressor response was similar before and after TMLR (an 11%±1% decrease of mean AoP, and a 6%±3% decrease of +dP/dt). However, after bilateral vagotomy, the depressor response to capsaicin was abolished in all 3 dogs. In the fourth dog, in whom capsaicin elicited a pressor response, the response still occurred after bilateral vagotomy.
Our results demonstrated there were no statistically significant differences in the responses to bradykinin or capsaicin between studies performed before and after TMLR. We found variable responses to topical application of bradykinin, but topical capsaicin consistently evoked pressor responses. Since the pressor and depressor responses remained intact after TMLR, there did not appear to be an effect on vagal or sympathetic responses.
We found that the pressor responses evoked by topical application of capsaicin were abolished after bilateral sympathectomy. The depressor responses induced by intracoronary injection of capsaicin were diminished after bilateral vagotomy. These results suggest that the pressor or depressor responses were reflex in nature and were mediated by sympathetic or vagal afferents rather than by direct drug actions on the heart or vessels. In our study, TMLR did not prevent cardiac afferent receptors from evoking reflex responses.
Cardiac reflexes are quite complicated and show large individual variation. A number of reflexes participate in the control of coronary vascular resistance through activation of the sympathetic or parasympathetic nervous system. It is well known that minute amounts of certain chemical substances introduced into the distribution of the left coronary artery or epicardium can initiate a powerful cardiac reflex.19,20 Stimulation of ventricular receptors can cause reflex hypotension and bradycardia (mediated by vagal afferents) or, alternatively, tachycardia and hypertension (mediated by sympathetic afferents).21 Responses also may result from simultaneous stimulation of vagal and sympathetic afferents.
The application of capsaicin to the epicardium of the left ventricle consistently results in increases in blood pressure and heart rate.22 Studies have shown that there are pressor and depressor responses to topical or intracoronary administration of these chemical agents. Felder and Thames16 reported that topical application of bradykinin elicited inhibitory, excitatory, and biphasic responses. Excitatory and inhibitory reflexes were eliminated by cardiac sympathetic afferent denervation. Injection of capsaicin into the left circumflex coronary artery caused systemic hypotension and bradycardia, a pressor response associated with tachycardia, or a biphasic effect. The reflex hypotension and bradycardia were reversed to increases in blood pressure and heart rate after bilateral vagotomy.17 Our results support these findings, with the exception that changes in heart rate were minimal, probably as a result of the barbiturate anesthesia. Anesthesia in general can inhibit reflex responses, and barbiturates have been known to attenuate neurally mediated changes in blood pressure and heart rate. Although the changes in heart rate and blood pressure that we report are relatively small, they are qualitatively comparable to what others have reported.16,22 In some cardiac reflex studies, α-chloralose, which may accentuate certain reflexes, has been used.17,23 With chloralose, however, the level of anesthesia may be light, making it necessary to use other anesthetics and drugs for muscular relaxation. Thus, there may be additional confounding variables. In a pilot study, we used isoflurane, but were not able to evoke cardiac chemoreflexes consistently. However, with a continuous infusion of pentobarbital, animals were well anesthetized, and the reflex changes in blood pressure and dP/dt were consistent; only the heart rate responses were variable. This could result from anesthesia, or perhaps from competing reflex responses.
Different results have been reported. In the study by Kwong et al,13 2 weeks after TMLR treatment, hemodynamic responses to topical bradykinin were not seen after stimulation of laser- or phenol-treated areas, but a depressor response was seen after stimulation of untreated areas in the same animals. These results are different from what we observed acutely with a lower concentration of bradykinin and might be explained by the direct effects of bradykinin on the vasculature or by the different TMLR treatment and recovery process. Arora et al,15 however, reported that sympathetic and parasympathetic cardiac afferent neurons that were activated electrically or chemically by epicardial application of bradykinin or veratridine induced similar ventricular augmentation before and after TMLR. Since TMLR did not appear to alter afferent or efferent axonal function in the treated ventricle, they concluded that the efficacy of TMLR could not be ascribed to local denervation.23 Our results support this concept and, in addition, show that activation of chemosensitive vagal and sympathetic afferent pathways by capsaicin or bradykinin persists after TMLR.
Studies have shown clearly that vagal and sympathetic nerves are close to the surface of the heart in the region of the atrioventricular groove. Vagal fibers then go deeper into the myocardium as they follow the distribution of the coronary arteries. Sympathetic fibers are found close to the myocardial surface in their distribution to the ventricle24 and may be more accessible to topical stimulation. This may explain the sympathetically mediated response to capsaicin that was prevalent in our experiments. In our study, whether the responses were evoked by bradykinin or capsaicin, and whether the chemicals stimulated the epicardial or intracoronary receptors, pressor or depressor responses remained intact after TMLR treatment.
The thermal and structural damage to the myocardium during TMLR is proportional to the laser wavelength, and a relatively large increase in damage imposed by the holmium (Ho):YAG laser has been reported.25 We used a Ho:YAG laser in our experiments with a density of 1 laser channel per square centimeter of myocardial surface; however, cardiac reflexes remained intact after TMLR. This result does not imply that laser treatment would not damage nerve endings. However, because of multiple endings of sympathetic afferent fibers, creation of laser channels in a relatively small region of the left ventricle is unlikely to cause complete denervation. From our experiments, we conclude that the myocardium is not denervated after TMLR, because cardiac chemoreflexes (vagal and sympathetic) remained intact. Therefore, our evidence supports the notion that improvement of symptoms of angina after TMLR is not likely caused by the denervation of the heart.
This study was supported in part by a grant from the Jewish Hospital Heart and Lung Foundation, Louisville, Ky.
Presented at the 107th Scientific Session of the Western Surgical Association, Santa Fe, NM, November 16, 1999.
Reprints: Robert Dowling, MD, Rudd Heart and Lung Center, Suite 1200, The Jewish Hospital, 201 Abraham Flexner Way, Louisville, KY 40202. Corresponding author: Benjamin B. Y. Chiang, MD, Division of Cardiothoracic Surgery, Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40292 (e-mail: firstname.lastname@example.org).
Thomas H. Cogbill, MD, La Crosse, Wis: Transmyocardial laser revascularization is emerging as a potential treatment option for advanced ischemic heart disease not amenable to angioplasty or coronary artery bypass grafting. In several recent multicenter clinical trials, this procedure has been shown to relieve angina. The mechanism of action is not known, but the 4 prevalent theories are (1) increased myocardial regional perfusion from laser channels, (2) induction of angiogenesis, (3) denervation of the myocardium, or (4) placebo effect.
Whether or not cardiac denervation is the mechanism by which TMLR relieves angina is important for 2 clinical reasons: (1) If TMLR causes denervation without improving myocardial performance, then compromise of the anginal warning system could be potentially dangerous. (2) If epicardial denervation is the explanation for anginal relief, then endocardial approaches to the procedure which are currently under development may be less successful.
Dr Chiang and coauthors hypothesized that it is unlikely that TMLR causes sufficient denervation of the myocardium to prevent transmission of the sensory information unless major proximal nerve branches are ablated. In a canine experimental model, they concluded that activation of cardiac afferent nerves and reflex responses remained intact after TMLR. These conclusions contradict the work by Kwong et al13 from Washington University in St Louis, but support a recent study by Hirsch et al23 from Halifax, Nova Scotia. Also, in a canine model, Hirsch's group showed that TMLR did not affect either afferent or efferent axonal function.
I have 3 questions for the authors. (1) How did you select the concentration of bradykinin for local application? Other investigators have used higher concentration in similar experiments. (2) Although you have demonstrated that direct activation of cardiac afferent nerves remained intact after TMLR, is it feasible that the local release of neuropeptide mediators involved in the sensation of pain is altered by TMLR? (3) Is nerve stimulation for sensation of pain an all-or-nothing response? Could there be a relative diminution of nerve stimulation which is responsible for reduction of anginal symptoms? Was your experimental model sensitive enough to detect such a relative decrease in nerve stimulation?
J. David Richardson, MD, Louisville, Ky: Transmyocardial revascularization appears to work even beyond a possible placebo effect. The question is why does it work. New vascular channels have been demonstrated, but often close early, while angina relief persists. Angiographic demonstrations of new vascular channels do not correlate well with angina relief. It is possible that epicardial inflammatory change induces neovascularity or angiogenesis that increases blood flow; or is the heart simply denervated? This latter possibility is the point addressed by the current paper.
There was a question that Dr Cogbill posed I will try to briefly answer. Regarding the dose of bradykinin, there was a range used from 10 to 100 µg that was in the physiologic range. Larger doses used by other investigators were not in the physiologic range.
Secondly, it is possible that the local nerves are destroyed, causing angina relief, while larger neural pathways remain intact. That is possible, and the present study does not absolutely exclude that explanation. Presently, biochemical studies are being analyzed to answer this question.
Thirdly, is nerve stimulation all or none, or could there be a blunted response that decreased angina? Dr Chiang and his colleagues do not believe that is the case; their studies indicated normal cardiac neuroreactivity and, therefore, this would be an unlikely explanation for the anginal relief seen.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA Surgery editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.